Close
ACHEMA MIDDLE EAST 2026

Water Unit of DuPont Has Some Potential Buyers Interested

The water treatment business of DuPont De Nemours Inc., which the US chemicals group happens to be planning to spin out, happens to be...

The Fauna Pharmaceutical Pollution: Scientists Sound Alarm

There is not a shred of doubt when we say that the ecosystem of the planet is getting contaminated due to Active Pharmaceutical Ingredients-...

4% CAGR Till 2030 For Water & Wastewater Treatment Equipment

As per Straits research, the worldwide water and wastewater treatment equipment market size, which was valued at $60 billion in 2021, is expected to...

Liquid Biopsy in Cancer Diagnostics: Definition and Advantages

Consulting firm Fortune Business Insights reports that the global market of liquid biopsy, the procedure of collecting cancer-related materials from bodily fluids, was valued...

Current E&L Issues And How Parenteral Packaging Is Evolving

In mid-2018, nitrosamine content, also called NDMA, was found to go beyond the guidelines when it came to the daily intake limits of a...

Great Point Partners Acquires Lyocontract – A German CDMO

On a mission so as to debut the life sciences companies on an international stage, Great Point Partners, the healthcare investment firm, is making...

Transforming In 2024 & Beyond – Prefilled Syringes Market

Prefilled syringes have gone on to make up a decent portion in terms of injectable packaging segment in the past 10 years. As per...

Subscribe Our Newsletter

White Papers

The Future of Digital Health

The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

Five Best Practices to Deliver Exceptional Multichannel Experiences

A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

The Impact and Use of Social Media in Pharmacovigilance

Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...